Skip to content

In Vitro Diagnostic Device for the Detection of Strep A

Multi-Center Study of an In Vitro Diagnostic Device for the Detection of Strep A

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02068469
Enrollment
799
Registered
2014-02-21
Start date
2013-12-31
Completion date
2014-04-30
Last updated
2016-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Streptococcal Sore Throat

Brief summary

The purpose of this trial is to show the accuracy and specificity of the Liat analyzer and assay for detecting Strep A at the point of care lab compared to culture.

Interventions

None listed

Sponsors

Roche Molecular Systems, Inc
CollaboratorINDUSTRY
IQuum, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who are 3 years of age or older * Subjects exhibiting symptoms characteristic of pharyngitis, possibly Streptococcus A, including: * presence of sore throat, and at least one other symptom from the list below: * redness of the posterior pharyngeal wall * pharyngeal or tonsillar exudate * tonsillar swelling * tender cervical lymphadenopathy * fever, \>38C at presentation or within the past 24 hours * Subjects who are able to understand and consent to participation; for minors under the age of 18, this includes parent or legal guardian

Exclusion criteria

* Subjects treated with antibiotics currently or within the previous 7 days.

Design outcomes

Primary

MeasureTime frame
Evaluate sensitivity and specificity of the Liat Strep A assay when compared to cultureResults based on samples collected at initial visit

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026